Here are the top 5 inflammation pieces of 2025; stay up-to-date with all the inflammation content from The American Journal ...

Discover the latest breakthroughs in myasthenia gravis treatment, including rozanolixizumab and nipocalimab, and insights on ...

Our content coverage from the Southeastern Educational Congress of Optometry (SECO) 2025 provided information on a mix of ...

Oral roflumilast showed potential as a nonbiologic systemic therapy for moderate to severe psoriasis, offering an alternative ...

Here are the top 5 ovarian cancer articles of 2025; stay up-to-date with all the ovarian cancer content from The American ...

The 2025 pharmaceutical pipeline is expanding with generics, biosimilars, and new therapies, despite delays from patent ...

The top Managed Care Cast episodes explored wellness visits, weight loss drug access, neurospine care, public health policy, ...

The GLOVe regimen, combining glofitamab, lenalidomide, and venetoclax, shows rapid and deep responses in high-risk MCL ...

Key Takeaways. TTP following R-CHOP is a strong prognostic factor for survival in R/R DLBCL, with shorter TTP linked to ...

The top 5 infectious disease stories on AJMC.com this year covered both outbreaks and government-related developments. Bird ...

Remote therapeutic monitoring (RTM) of patients with blood cancers cut hospitalizations from infections by 52% over 2 years ...

The future treatment landscape for follicular lymphoma is being rapidly shaped by several promising agents and novel ...